Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor - PubMed (original) (raw)
. 2010 Apr;51(4):2109-17.
doi: 10.1167/iovs.09-3993. Epub 2009 Dec 10.
Affiliations
- PMID: 20007828
- DOI: 10.1167/iovs.09-3993
Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor
Lina Zhang et al. Invest Ophthalmol Vis Sci. 2010 Apr.
Abstract
Purpose. Aryl hydrocarbon receptor (AHR) has been identified as a regulator of CD25(+)CD4(+) regulatory T-cell (T(reg)) and Th17 cell differentiation in mice, and activation of AHR by its ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces functional T(reg) cells. In this study, the authors examined whether the AHR-mediated effect of TCDD suppresses mouse experimental autoimmune uveitis (EAU) by inducing T(reg) cell differentiation. Methods. C57BL/6 mice were injected with TCDD 1 day before immunization with human interphotoreceptor retinoid-binding protein peptide 1-20 (hIRBP-p), and the severity of EAU was assessed clinically and histopathologically. Immunologic responses of draining lymph node cells and splenocytes to hIRBP-p and anti-CD3 monoclonal antibody (mAb) were assessed by T-cell proliferation and cytokine production. In addition, differentiation of Foxp3(+) T cells and their immunosuppressive roles in TCDD-injected mice were evaluated. Results. TCDD injection increased Foxp3(+) T cells in the lymph nodes and in the spleen. Development of EAU was completely suppressed by TCDD injection, and suppression was abolished by treatment with anti-CD25 mAb before TCDD injection. Both lymphocytes and splenocytes obtained from TCDD-injected mice immunized with hIRBP-p failed to produce IFN-gamma and IL-17 on stimulation with hIRBP-p, and the failure of IL-17 production was observed even when stimulated with anti-CD3 mAb. However, this protocol did not interfere with IL-10 production and T-cell proliferation response when assessed on stimulation with anti-CD3 mAb. Conclusions. Activation of AHR by TCDD markedly suppressed autoimmune uveoretinitis through mechanisms that expand CD25(+)Foxp3(+) T(reg) cells and interfere with the activation of Th1 and Th17 cells.
Similar articles
- Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H, Ohguro N, Fujimoto M, Hohki S, Terabe F, Serada S, Nomura S, Nishida K, Kishimoto T, Naka T. Haruta H, et al. Invest Ophthalmol Vis Sci. 2011 May 17;52(6):3264-71. doi: 10.1167/iovs.10-6272. Invest Ophthalmol Vis Sci. 2011. PMID: 21330657 - Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice.
Usui Y, Takeuchi M, Hattori T, Okunuki Y, Nagasawa K, Kezuka T, Okumura K, Yagita H, Akiba H, Goto H. Usui Y, et al. Arch Ophthalmol. 2009 Apr;127(4):514-9. doi: 10.1001/archophthalmol.2009.34. Arch Ophthalmol. 2009. PMID: 19365033 - Suppression of experimental autoimmune uveitis by angiotensin II type 1 receptor blocker telmisartan.
Okunuki Y, Usui Y, Nagai N, Kezuka T, Ishida S, Takeuchi M, Goto H. Okunuki Y, et al. Invest Ophthalmol Vis Sci. 2009 May;50(5):2255-61. doi: 10.1167/iovs.08-2649. Epub 2009 Jan 10. Invest Ophthalmol Vis Sci. 2009. PMID: 19136706 - [Translational research with experimental autoimmune uveoretinitis (EAU)].
Usui M. Usui M. Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):137-58; discussion 159. Nippon Ganka Gakkai Zasshi. 2007. PMID: 17402560 Review. Japanese. - The possible roles of environmental factors and the aryl hydrocarbon receptor in the prevalence of thyroid diseases in Vietnam era veterans.
Spaulding SW. Spaulding SW. Curr Opin Endocrinol Diabetes Obes. 2011 Oct;18(5):315-20. doi: 10.1097/MED.0b013e32834a8764. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21825977 Review.
Cited by
- Novel AHR ligand AGT-5 ameliorates type 1 diabetes in mice through regulatory cell activation in the early phase of the disease.
Jonić N, Koprivica I, Kyrkou SG, Bistas VP, Chatzigiannis C, Radulović N, Pilipović I, Jovanović A, Jovanović MB, Dimitrijević M, Tzakos AG, Stojanović I. Jonić N, et al. Front Immunol. 2024 Sep 6;15:1454156. doi: 10.3389/fimmu.2024.1454156. eCollection 2024. Front Immunol. 2024. PMID: 39308860 Free PMC article. - Autoimmune uveitis attenuated in diabetic mice through imbalance of Th1/Th17 differentiation via suppression of AP-1 signaling pathway in Th cells.
Takeuchi M, Nishio Y, Someya H, Sato T, Yoshimura A, Ito M, Harimoto K. Takeuchi M, et al. Front Immunol. 2024 Jun 3;15:1347018. doi: 10.3389/fimmu.2024.1347018. eCollection 2024. Front Immunol. 2024. PMID: 38887289 Free PMC article. - AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2-STAT3 signaling pathway.
Zhang Y, Pan Y, Zhang P, Wang F, Han Y, Li K, Jiang W, Wang J, Luan Y, Xin Q. Zhang Y, et al. Immun Inflamm Dis. 2023 Jun;11(6):e903. doi: 10.1002/iid3.903. Immun Inflamm Dis. 2023. PMID: 37382269 Free PMC article. - The role of transcription factors in shaping regulatory T cell identity.
Trujillo-Ochoa JL, Kazemian M, Afzali B. Trujillo-Ochoa JL, et al. Nat Rev Immunol. 2023 Dec;23(12):842-856. doi: 10.1038/s41577-023-00893-7. Epub 2023 Jun 19. Nat Rev Immunol. 2023. PMID: 37336954 Free PMC article. Review. - Current Therapeutic Landscape and Safety Roadmap for Targeting the Aryl Hydrocarbon Receptor in Inflammatory Gastrointestinal Indications.
Faber SC, Lahoti TS, Taylor ER, Lewis L, Sapiro JM, Toledo Sales V, Dragan YP, Jeffy BD. Faber SC, et al. Cells. 2022 May 21;11(10):1708. doi: 10.3390/cells11101708. Cells. 2022. PMID: 35626744 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials